ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 79 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $296,000 | -16.9% | 41,636 | 0.0% | 0.00% | – |
| Q4 2018 | $356,000 | -79.0% | 41,636 | -50.7% | 0.00% | -100.0% |
| Q3 2018 | $1,692,000 | +42.4% | 84,512 | +83.8% | 0.00% | 0.0% |
| Q2 2018 | $1,188,000 | +18.1% | 45,974 | +9.2% | 0.00% | 0.0% |
| Q1 2018 | $1,006,000 | -22.2% | 42,088 | +10.3% | 0.00% | 0.0% |
| Q4 2017 | $1,293,000 | -2.5% | 38,149 | -39.1% | 0.00% | 0.0% |
| Q3 2017 | $1,326,000 | +68.3% | 62,651 | +39.0% | 0.00% | 0.0% |
| Q2 2017 | $788,000 | -2.1% | 45,059 | -2.0% | 0.00% | 0.0% |
| Q1 2017 | $805,000 | -0.5% | 45,994 | -3.9% | 0.00% | 0.0% |
| Q4 2016 | $809,000 | -8.8% | 47,866 | -11.4% | 0.00% | 0.0% |
| Q3 2016 | $887,000 | +6.9% | 54,036 | -1.4% | 0.00% | 0.0% |
| Q2 2016 | $830,000 | +58.1% | 54,796 | +51.0% | 0.00% | – |
| Q1 2016 | $525,000 | -46.6% | 36,297 | +4.6% | 0.00% | -100.0% |
| Q4 2015 | $983,000 | +69.2% | 34,699 | 0.0% | 0.00% | – |
| Q3 2015 | $581,000 | +0.3% | 34,699 | +57.3% | 0.00% | – |
| Q2 2015 | $579,000 | +248.8% | 22,066 | +132.3% | 0.00% | – |
| Q1 2015 | $166,000 | +0.6% | 9,497 | 0.0% | 0.00% | – |
| Q4 2014 | $165,000 | -7.3% | 9,497 | -0.8% | 0.00% | – |
| Q3 2014 | $178,000 | +17.1% | 9,575 | +14.9% | 0.00% | – |
| Q2 2014 | $152,000 | – | 8,335 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|